ArticleJournal of translational medicine2026
FAP-targeted ROS-responsive nanoparticles delivering siBTF3 modulate the TME to enhance immunotherapy in colorectal cancer.
Feihu Yan et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.